New menopause guidelines designed to cut through misinformation

Menopause, a natural phase of life marking the end of a woman's reproductive years, can bring various symptoms that impact quality of life. The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) has introduced new clinical guidelines to help cut through misinformation and provide clear, evidence-based recommendations for clinicians. These guidelines address menopausal hormone therapy (MHT) versus other medicines and treatment options for those with a history of breast cancer.

RANZCOG chair Catriona Melville emphasized the importance of providing clear, evidence-based advice to help clinicians discuss treatment options with their patients. The guidelines cover vasomotor symptoms like hot flushes and night sweats, as well as genito-urinary symptoms such as vaginal dryness and frequent urination in women aged 40 and above. However, they do not cover bone density, joint pain, libido, depression, or anxiety management.

Expert Magdalena Simonis highlighted that not all women experience the same symptoms or severity. She stressed the need for clinicians to consider lifestyle and other risk factors, including cholesterol, bone density, and overall health. While menopausal hormone therapy, acupuncture, and hypnosis are among the treatment options, there is insufficient evidence to support weight loss, physical activity, or hypnosis as effective in alleviating hot flushes or night sweats.

The guidelines recommend annual doctor visits for women taking MHT, but they do not endorse weight loss or physical activity alone as effective remedies for menopausal symptoms. Dr. Melville noted that these are the first evidence-based guidelines from RANZCOG, aiming to standardize recommendations across Australia. Jean Hailes for Women's Health CEO Sarah White emphasized the importance of having these guidelines to combat online misinformation and ensure patients receive the best support.

The guidelines also encourage clinicians to inquire about troubling symptoms in women approaching menopause, particularly for First Nations, Māori, Pacific Islander, and other groups facing treatment barriers. This proactive approach aims to make it easier for women to seek help. The Australian government is funding separate perimenopause and menopause guidelines to be released next year, which RANZCOG will contribute to and continually update as new evidence emerges.

Dr. Simonis encouraged women experiencing troublesome symptoms to consult their GP and schedule a check-up, reassuring them that menopause is a natural phase of life.